Animal Experiments
The question
To ask the Secretary of State for Science, Innovation and Technology, with reference to the UK’s Modern Industrial Strategy, CP 1337, published on 23 June 2025, what assessment he has made of the potential impact of prioritising frontier life sciences industries in pharmaceuticals on (a) developing non-animal methods of testing and (b) phasing out animal testing.
Answered by Kanishka Narayan
The Government is committed to supporting non-animal alternatives and will publish a strategy to support their development, validation and adoption.
Frontier life science companies are pioneering innovative drug development, including via human-specific targets that require human-based models in their discovery and testing, and alternative technologies that can be used to support this, such as AI and machine learning. Supporting these industries will help advance alternative methods and contribute to the reduction of animal testing, in alignment with the forthcoming government strategy on alternatives.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →